André de Villers

President at CEMA, Inc.

André de Villers

André de Villers

President at CEMA, Inc.

Overview
Career Highlights

CEMA, Inc.
Theratechnologies, Inc.
CelMed BioSciences, Inc.

RelSci Relationships

92

Number of Boards

6

Relationships
RelSci Relationships are individuals André de Villers likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Alizé Pharma SAS

Relationship likelihood: Strong

Co-Founder at Alizé Pharma SAS

Relationship likelihood: Strong

Co-Founder at Alizé Pharma SAS

Relationship likelihood: Strong

President & Founder at Orega Biotech SAS

Relationship likelihood: Strong

Vice President, Clinical Development at Millendo Therapeutics, Inc.

Relationship likelihood: Strong

Venture Partner at Ventech SA

Relationship likelihood: Strong

Managing Partner at Sofimac Innovation SAS

Relationship likelihood: Strong

Senior Investment Director at BPIFrance Investissement SAS

Relationship likelihood: Strong

President, Chief Executive Officer & Non-Independent Director at TSO3, Inc.

Relationship likelihood: Strong

Co-Founder at TSO3, Inc.

Relationship likelihood: Strong

Paths to André de Villers
Potential Connections via
Relationship Science
You
André de Villers
President at CEMA, Inc.
Education
Undergraduate Degree
Class of 1973

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Career History
Director
2007 - Current

Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

President
Current

CEMA, Inc. operates as an investment holding company. The company is headquartered in Montreal, Canada.

President & Chief Executive Officer
2004 - 2006

Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada.

Boards & Committees
Member, Board of Directors
2007 - Current

Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Director
Current

Alizé Pharma II SAS engages in the development of biopharmaceutical drugs, proteins and peptides, for the treatment of metabolic diseases and rare diseases. Its lead assets are pegcrisantaspase (Asparec), a PEGylated recombinant L-asparaginase from Erwinia chrysanthemi, and related intellectual property. The company was founded in 2008 and is headquartered in Ecully, France.

Director
Current
Investments
Details Hidden

Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.